Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Privitera

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Advances in Therapy|January 27, 2026
Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn's Disease and their Role in Patients with Low-Risk FeaturesAngelo Del Gaudio, Laura Parisio, Giuseppe Privitera, et al.
Frontiers in Immunology|August 20, 2025
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel diseaseDiletta De Deo, Arianna Dal Buono, Roberto Gabbiadini, et al.
Future Oncology (London, England)|December 8, 2015
Follicular dendritic cell sarcoma of mediastinum: a key role of radiotherapy in a multidisciplinary approachCorrado Spatola, Marcello Migliore, Rocco Luca Emanuele Liardo, et al.
Future Oncology (London, England)|April 18, 2018
Combined taxane-based chemotherapy and intensity-modulated radiotherapy with simultaneous integrated boost for gastroesophageal junction adenocarcinomaCorrado Spatola, Alessandra Tocco, Antonio Pagana, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2025
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER StudyGiuseppe Privitera, Lucia Monastero, Elena Melita, et al.
Neurosurgical Focus|December 2, 2014
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cyclesGiuseppe M V Barbagallo, Sabrina Paratore, Rosario Caltabiano, et al.
Future Oncology (London, England)|December 8, 2015
Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experienceMarcello Migliore, Damiano Calvo, Alessandra Criscione, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2020
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patientsLorenzo Bertani, Domenico Tricò, Daniela Pugliese, et al.
European Journal of Radiology Open|August 5, 2016
Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapyPietro Valerio Foti, Giuseppe Privitera, Sebastiano Piana, et al.
Inflammatory Bowel Diseases|July 29, 2020
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical ImplicationsFranco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Advances in Therapy|January 27, 2026
Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn's Disease and their Role in Patients with Low-Risk FeaturesAngelo Del Gaudio, Laura Parisio, Giuseppe Privitera, et al.
Frontiers in Immunology|August 20, 2025
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel diseaseDiletta De Deo, Arianna Dal Buono, Roberto Gabbiadini, et al.
Future Oncology (London, England)|December 8, 2015
Follicular dendritic cell sarcoma of mediastinum: a key role of radiotherapy in a multidisciplinary approachCorrado Spatola, Marcello Migliore, Rocco Luca Emanuele Liardo, et al.
Future Oncology (London, England)|April 18, 2018
Combined taxane-based chemotherapy and intensity-modulated radiotherapy with simultaneous integrated boost for gastroesophageal junction adenocarcinomaCorrado Spatola, Alessandra Tocco, Antonio Pagana, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2025
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER StudyGiuseppe Privitera, Lucia Monastero, Elena Melita, et al.
Neurosurgical Focus|December 2, 2014
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cyclesGiuseppe M V Barbagallo, Sabrina Paratore, Rosario Caltabiano, et al.
Future Oncology (London, England)|December 8, 2015
Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experienceMarcello Migliore, Damiano Calvo, Alessandra Criscione, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2020
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patientsLorenzo Bertani, Domenico Tricò, Daniela Pugliese, et al.
European Journal of Radiology Open|August 5, 2016
Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapyPietro Valerio Foti, Giuseppe Privitera, Sebastiano Piana, et al.
Inflammatory Bowel Diseases|July 29, 2020
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical ImplicationsFranco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, et al.
Pageof 10